Stock Spotlight Archives - Page 232 of 392

FridayOct 02, 2020 1:43 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd., UltraPlay to Enhance Customer Engagement Through Loyalty, Gamification Programs and Cutting-Edge Tech

Mobius Interactive, a new online gaming operator with a variety of diverse offerings, has partnered with leading eSports and iGaming platform — UltraPlay — to attract a global network of high-net-worth gamers. The two companies are collaborating to enhance customer engagement through the use of loyalty and gamification programs. A recent article discussing this reads, “Currently, Mobius is partnering with UltraPlay to offer more than 34 unique games and sports betting available 24/7. Mobius’ sports betting product has a wide range of functionalities, mystery jackpots, cutting-edge tech and live and pre-match odds. In addition, the company’s live casino games are…

FridayOct 02, 2020 1:28 pm

QualityStocksNewsBreaks – Cybin Corp. CEO Eyes Opportunity in Psychedelics Space, Organic IP Expansion

Cybin Corp., a Canada-based, life-science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, recently announced the appointment of Doug Drysdale as the company’s chief executive officer. Well recognized in the pharmaceutical space, Drysdale brings more than three decades of experience and a recognition of psychedelics as a major breakthrough in treating mental health conditions. Amid the recent strong push for research and commercialization in the psychedelics sector, Drysdale seeks to pursue emerging opportunities and pave the road for the company’s rapid growth. “I am beyond excited to be joining the Cybin team,” Drysdale stated in a recent article of…

FridayOct 02, 2020 1:07 pm

QualityStocksNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CIO Discusses Convergence of AI, Data and Biology on DojoLIVE!

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent article discussing the appearance of one of its executives, Helomics CIO Mark Collins, PhD, on DojoLIVE! (https://ibn.fm/Y9fBZ). POAI’s Helomics subsidiary applies AI to its rich data gathered from more than 150,000 tumors in an effort to personalize cancer therapies and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Collins addressed this powerful work and his longtime passion during the interview titled, “Can We Cure Cancer with Artificial Intelligence?” “The last 20 years of…

FridayOct 02, 2020 12:46 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Setting the Stage for Success in Bringing Novel Products to Market

180 Life Sciences, a clinical-stage biotechnology company, is focused on research to solve one of the world’s most significant drivers of disease – inflammation. The company currently has three programs for the development of novel drugs in the areas of fibrosis and anti-TNF, inflammatory pain and ulcerative colitis in ex-smokers. A recent article discusses the company’s strategy to expedite the path to market. The piece reads, “180 Life Sciences has mitigated the risks of its drug development through multiple programs at various stages of development. The company is actively decreasing costs and expediting the time to market by using grant…

MondaySep 28, 2020 2:44 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Deploys Traditional, Customized Techniques to Enable Successful ‘Golden Mile’ Harvest

Pac Roots (CSE: PACR), a Canadian cannabis company dedicated to producing premium-quality strains and products, is ramping up for a Fall 2020 harvest at its joint venture site with Rock Creek Farms, a 100-acre commercial hemp operation located in a productive area of British Columbia known as the “Golden Mile.” The partners leverage customary and new methods for quality production and expect to begin harvesting on October 15, 2020, with an initial projected biomass yield of 500,000 – 700,000 pounds. A recent article discussing this reads, “PacRoots and Rock Creek Farms have deployed several traditional and customized hemp farming techniques…

MondaySep 28, 2020 2:24 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Making Strategic Moves Amid Surging Demand

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), engaged in the business of acquiring and exploring mineral resource properties, was featured in a recent editorial. The piece, titled “One of ‘World’s Best-Performing Mainstream Assets,’ Gold Heading for Record Highs,” addresses several savvy mining resource companies that are making strategic moves amid global economic conditions and surging demand as investors turn to gold. The article reads, “Recognizing long-term trends, GoldHaven Resources is making significant moves in the gold mining industry. In the business of acquiring and exploring mineral resource properties, the Canada-based exploration company has so far identified four of its seven properties…

FridaySep 25, 2020 2:41 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Advancing Lead Program, Plans Additional Clinical Trials

180 Life Sciences, a clinical-stage biotechnology company, is dedicated to producing solutions designed to battle inflammation when the body’s natural processes go awry. The company’s primary focus is to treat fibrosis and inflammation using anti-TNF therapy, designed to block the activity of TNF, a substance in the body that can cause inflammation and lead to immune-system diseases. The company is advancing on this front as discussed by a recent article that reads, “180 Life Sciences’ lead program is in phase 2b/3 clinical trials and expects to deliver its first results next year. Other clinical trials planned by the company are…

FridaySep 25, 2020 2:18 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Sequire Provides Key Insight for Public Company Execs

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology products, gives public companies an edge with critical data to successfully activate media campaigns, engage shareholders and attract investment. The company’s data analytics platform – Sequire – has proven a key tool for decision makers in the public realm, recently doubling its user base to amass over 1 million active investors and traders. A recent article discussing this quotes SRAX founder and CEO Christopher Miglino, who states, “We are creating a community of public company executives that are taking back their data. For too long these leaders have relied…

FridaySep 25, 2020 2:07 pm

QualityStocksNewsBreaks – Cybin Corp. Leverages Two-Pronged Approach to Target Psychedelic, Nutraceutical Sectors

Cybin Corp., a Canada-based life-science company, looks to benefit from its growing footprint in two billion-dollar markets: nutraceuticals and psychedelic drugs. Both sectors are projected to see significant growth in the coming years. The global nutraceutical market was valued at $382.51 billion in 2019 and is expected to grow at an 8.3% compound annual growth rate (“CAGR”) over the next seven years. Meanwhile, the psychedelic drugs market is projected to reach $6.85 billion by 2027. Cybin’s business model is structured around two wholly owned divisions focused on targeting both promising spaces. A recent article discussing this reads, “Cybin is committed…

Site Search

Company Search

Category: Stock Spotlight